Comparative in-vitro activity of moxifloxacin, minocycline and azithromycin against Chlamydia spp.

Journal of Antimicrobial Chemotherapy

Volumn 43, Issue 6, 1999, Pages 825-827

  Donati, M ^a   Rodriguez Fermepin M ^a   Olmo, A ^a   D'Apote, L ^a   Cevenini, R ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; MACROLIDE; MINOCYCLINE; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; CHLAMYDOPHILA PSITTACI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

EID: 0344242064     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/43.6.825     Document Type: Article

References (10)

1. Peeling, R.W. & Brunham, R. C. (1996). Chlamydiae as pathogens: new species and new issues. Emerging Infectious Diseases 2, 307-19.
2. Dalhoff, A., Petersen, U. & Endermann, R. (1996). In vitro activity of BAY 12-8039, a new 8-methoxyquinolone. Chemotherapy 42, 410-25.
3. Fass, R. J. (1997). In vitro activity of Bay 12-8039, a new 8-methoxyquinolone. Antimicrobial Agents and Chemotherapy 41, 1818-24.
4. Bebear, C. M., Renaudin, H., Boudjada, A. & Bebear, C. (1998). In vitro activity of Bay 12-8039, a new fluoroquinolone, against mycoplasmas. Antimicrobial Agents and Chemotherapy 42, 703-4.
5. Hammerschlag, M. R., Hyman, C. L. & Roblin, P. M. (1992). In vitro activities of five quinolones against Chlamydia pneumoniae. Antimicrobial Agents and Chemotherapy 36, 682-3.
6. Woodcock, J. M., Andrews, J. M., Boswell, F. J., Brenwald, N. P. & Wise, R. (1997). In vitro activity of BAY 12-8039, a new fluoroquinolone. Antimicrobial Agents and Chemotherapy 41, 101-6.
7. Forsey, T., Darougar, S. & Treharne, J. D. (1986). Prevalence in human beings of antibodies to Chlamydia IOL-207, an atypical strain of chlamydia. Journal of Infection 12, 145-52.
8. Cevenini, R., Donati, M., Sambri, V., Rumpianesi, F. & La Placa, M. (1987). Reactivity of elementary bodies of Chlamydia trachomatis LGV2 with monoclonal antibodies specific for the major outer membrane protein. FEMS Microbiology Letters 42, 47-51.
9. Roblin, P. M, Kutlin, A. & Hammerschlag, M. R. (1997). In vitro activity of trovafloxacin against Chlamydia pneumoniae. Antimicrobial Agents and Chemotherapy 41, 2033-4.
10. Miyashita, N., Niki, Y., Kishimoto, T., Nakajima, M. & Matsushima, T. (1997). In vitro and in vivo activities of AM-1155, a new fluoroquinolone, against Chlamydia spp. Antimicrobial Agents and Chemotherapy 41, 1331-4.